m+Medelevator.RU
← Поиск публикаций
Journal of chemotherapy (Florence, Italy) · 2022

Carbapenem-resistant Gram-negative pathogens associated with septic shock: a review of 120 cases.

ОбзорСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Önal Uğur, Akyol Deniz, Mert Merve, Başkol Dilşah, Memetali Seichan Chousein, Şanlıdağ Gamze, Kenanoğlu Buse, Uyan-Önal Ayşe, Quliyeva Günel, Avşar Cansu Bulut, Akdağ Damla, Demir Melike, Erdem Hüseyin Aytaç, Kahraman Ümit, Bozbıyık Osman, Özgiray Erkin, Bozkurt Devrim, Akarca Funda Karbek, Demirağ Kubilay, Çankayalı İlkin, Uyar Mehmet, Çilli Feriha, Arda Bilgin, Yamazhan Tansu, Pullukçu Hüsnü, Taşbakan Meltem Işıkgöz, Sipahi Hilal, Ulusoy Sercan, Sipahi Oguz Resat

Аннотация

This study aimed to evaluate the influencing variables for outcomes in patients with septic shock having culture-proven carbapenem-resistant Gram-negative pathogens. It included 120 patients (mean age 64.29 ± 1.35 years and 58.3% female). The mean Sequential Organ Failure Assessment score during septic shock diagnosis was found to be 11.22 ± 0.43 and 9 ± 0.79 among the patients with mortality and among the survivors, respectively (P = 0.017). The logistic regression analysis showed that empirical treatment as mono Gram-negative bacteria-oriented antibiotic therapy (P = 0.016, odds ratio (OR) = 17.730, 95% confidence interval (CI): 1.728-182.691), Charlson Comorbidity Index >2 (P = 0.032, OR = 7.312, 95% CI: 5.7-18.3), and systemic inflammatory response syndrome score 3 or 4 during septic shock diagnosis (P = 0.014, OR = 5.675, 95% CI: 1.424-22.619) were found as independent risk factors for day 30 mortality. Despite early diagnosis and effective management of patients with septic shock, the mortality rates are quite high in CRGNP-infected patients.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты